Taken together with results obtained from the AAV virus injection experiments, these results indicate that p38 MAPK may be a critical downstream molecular target of βCaMKII in modulating the COX-2/PGE2 pathway and behavioral responses related to depression. This evidence concerns the gene PTGS2 and depressive symptom measurement.